RhumbLine Advisers
BDTX icon

RhumbLine Advisers’s Black Diamond Therapeutics BDTX Stock Holding History

RhumbLine Advisers’s Portfolio BDTX Stock Details BDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-54,836
Closed -$85K – 4151
2025
Q1 		$85K Sell
54,836
-1,299
-2% -$2.72K ﹤0.01% 3446
2024
Q4 		$120K Buy
56,135
+7,290
+15% +$20.9K ﹤0.01% 3422
2024
Q3 		$212K Buy
48,845
+1,995
+4% +$10.9K ﹤0.01% 3209
2024
Q2 		$218K Buy
46,850
+46,401
+10,334% +$249K ﹤0.01% 3178
2024
Q1 		$2.28K Hold
449
– – ﹤0.01% 4079
2023
Q4 		$1.26K Hold
449
– – ﹤0.01% 4136
2023
Q3 		$1.29K Hold
449
– – ﹤0.01% 4160
2023
Q2 		$2.27K Buy
+449
New +$917 ﹤0.01% 4200
2022
Q2 		– Sell
-29,064
Closed -$81K – 3108
2022
Q1 		$81K Sell
29,064
-1,749
-6% -$6.39K ﹤0.01% 2926
2021
Q4 		$164K Sell
30,813
-580
-2% -$4.05K ﹤0.01% 2875
2021
Q3 		$266K Buy
31,393
+1,075
+4% +$10.6K ﹤0.01% 2811
2021
Q2 		$370K Buy
30,318
+12,012
+66% +$237K ﹤0.01% 2696
2021
Q1 		$444K Sell
18,306
-1,105
-6% -$29.8K ﹤0.01% 2544
2020
Q4 		$622K Buy
19,411
+2,392
+14% +$78.6K ﹤0.01% 2344
2020
Q3 		$514K Buy
17,019
+1,879
+12% +$57.2K ﹤0.01% 2279
2020
Q2 		$638K Buy
15,140
+3,079
+26% +$113K ﹤0.01% 2234
2020
Q1 		$301K Buy
+12,061
New +$367K ﹤0.01% 2401

Other funds holding BDTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

RhumbLine Advisers's BDTX Position: Q2 2025 in Review

RhumbLine Advisers sold out of Black Diamond Therapeutics (BDTX) in Q2 2025, closing a stake of 54,836 shares — an estimated $85K sold.

RhumbLine Advisers first reported a position in BDTX in Q1 2020 and held it in 17 quarters. The position peaked at $638K in Q2 2020. 94 funds tracked by Wall St. Rank hold BDTX as of Q2 2025.

  • RhumbLine Advisers reported no remaining Black Diamond Therapeutics position as of Q2 2025 after selling out during the quarter.
  • RhumbLine Advisers sold 54,836 Black Diamond Therapeutics shares in Q2 2025, an estimated $85K.
  • RhumbLine Advisers first reported a position in Black Diamond Therapeutics in Q1 2020 and held it in 17 quarters.
  • RhumbLine Advisers's Black Diamond Therapeutics position peaked at $638K in Q2 2020.
  • 94 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q2 2025.

Based on RhumbLine Advisers's 13F filing for Q2 2025, filed 12 Aug 2025.